American Trust Edwards Lifesciences Corp Transaction History

American Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2022	SELL	$82.37 - $107.29 $750,061 - $976,982	-9,106 Closed	0 $0
Q2 2022 Oct 03, 2022	SELL	$86.5 - $128.27 $253,531 - $375,959	-2,931 Reduced 24.35%	9,106 $866,000
Q1 2022 Jun 08, 2022	SELL	$101.96 - $128.34 $49,144 - $61,859	-482 Reduced 3.85%	12,037 $1.42 Million
Q4 2021 Mar 17, 2022	BUY	$106.37 - $130.68 $1.33 Million - $1.64 Million	12,519 New	12,519 $1.62 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.